Analysis of interleukin-10 promoter single nucleotide polymorphisms and risk of non-Hodgkin lymphoma in a Malaysian population

References

• Evans LS, Hancock BW. Non-Hodgkin lymphoma. Lancet 2003; 362:139–146.
   PubMed Web of Science ®Google Scholar
• Ariffin OZ, Saleha ITN. NCR report 2007. Malaysia: Ministry of Health; 2011.
   Google Scholar
• Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet 2012;380:848–857.
   PubMed Web of Science ®Google Scholar
• Saraiva M, O’Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010;10:170–181.
   PubMed Web of Science ®Google Scholar
• Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005;5:263–274.
   PubMed Web of Science ®Google Scholar
• Khatri VP, Caligiuri MA. A review of the association between interleukin-10 and human B-cell malignancies. Cancer Immunol Immunother 1998;46:239–244.
   PubMed Web of Science ®Google Scholar
• Hofmann SR ER, Zhou YJ, et al. Cytokines and their role in lymphoid development, differentiation and homeostasis. Curr Opin Allergy Clin Immunol 2002;2:495–506.
   PubMed Web of Science ®Google Scholar
• MacNeil IA, Suda T, Moore KW, et al. IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 1990;145:4167–4173.
   PubMed Web of Science ®Google Scholar
• Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992;89:1890–1893.
   PubMed Web of Science ®Google Scholar
• Go NF, Castle BE, Barrett R, et al. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990;172:1625–1631.
   PubMed Web of Science ®Google Scholar
• Voorzanger N, Touitou R, Garcia E, et al. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res 1996;56:5499–5505.
   PubMed Web of Science ®Google Scholar
• Inagaki A, Ishida T, Ishii T, et al. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors. Int J Cancer 2006;118:3054–3061.
   PubMed Web of Science ®Google Scholar
• Blay JY, Burdin N, Rousset F, et al. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 1993;82:2169–2174.
   PubMed Web of Science ®Google Scholar
• Lech-Maranda E, Bienvenu J, Michallet AS, et al. Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma. Eur Cytokine Netw 2006;17:60–66.
   PubMed Web of Science ®Google Scholar
• el-Far M, Fouda M, Yahya R, et al. Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma. J Physiol Biochem 2004;60:253–258.
   PubMed Web of Science ®Google Scholar
• Stasi R, Zinzani PL, Galieni P, et al. Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non-Hodgkin's lymphoma. Br J Haematol 1994;88:770–777.
   PubMed Web of Science ®Google Scholar
• Czarneski J, Lin YC, Chong S, et al. Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma. Leukemia 2004;18:597–606.
   PubMed Web of Science ®Google Scholar
• Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 2005;78:1043–1051.
   PubMed Web of Science ®Google Scholar
• Cervenak L, Morbidelli L, Donati D, et al. Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood 2000;96:2568–2573.
   PubMed Web of Science ®Google Scholar
• Costeas PA, Koumas L, Koumouli A, et al. Cytokine polymorphism frequencies in the Greek Cypriot population. Eur J Immunogenet 2003;30:341–343.
   PubMedGoogle Scholar
• Lan Q, Zheng T, Rothman N, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 2006;107:4101–4108.
   PubMed Web of Science ®Google Scholar
• Rothman N, Skibola CF, Wang SS, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006;7:27–38.
   PubMed Web of Science ®Google Scholar
• Breen EC, Boscardin WJ, Detels R, et al. Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter -592 C/C genotype. Clin Immunol 2003;109:119–129.
   PubMed Web of Science ®Google Scholar
• Purdue MP, Lan Q, Kricker A, et al. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 2007;28:704–712.
   PubMed Web of Science ®Google Scholar
• Minnicelli C, Barros MH, Klumb CE, et al. Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma. PLoS One 2012;7:e46005.
   Web of Science ®Google Scholar
• Gibson AW, Edberg JC, Wu J, et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001;166:3915–3922.
   PubMed Web of Science ®Google Scholar
• Salhi A, Rodrigues V Jr, Santoro F, et al. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J Immunol 2008;180:6139–6148.
   PubMed Web of Science ®Google Scholar
• Sun F, Sun Y, Zhang D, et al. Association of interleukin-10 gene polymorphism with cachexia in Chinese patients with gastric cancer. Ann Clin Lab Sci 2010;40:149–155.
   PubMed Web of Science ®Google Scholar
• Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1–8.
   PubMedGoogle Scholar
• Eskdale J, Keijsers V, Huizinga T, et al. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1999;1:151–155.
   PubMed Web of Science ®Google Scholar
• Zeng L, Gu W, Chen K, et al. Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies. Crit Care 2009;13:R188.
   PubMed Web of Science ®Google Scholar
• Crawley E, Kay R, Sillibourne J, et al. Polymorphic haplotypes of the interleukin-10 5’ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999;42:1101–1108.
   PubMed Web of Science ®Google Scholar
• Bogunia-Kubik K, Mazur G, Wrobel T, et al. Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma. Tissue Antigens 2008;71:146–150.
   PubMed Web of Science ®Google Scholar
• Lee JJ, Kim DH, Lee NY, et al. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas. Br J Haematol 2007;137:329–336.
   PubMed Web of Science ®Google Scholar
• Levy Y, Brouet JC. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest 1994;93:424–428.
   PubMed Web of Science ®Google Scholar
• Alas S, Emmanouilides C, Bonavida B. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis. Clin Cancer Res 2001;7:709–723.
   PubMed Web of Science ®Google Scholar
• Cohen SB, Crawley JB, Kahan MC, et al. Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology 1997;92:1–5.
   PubMed Web of Science ®Google Scholar
• Gupta M, Han JJ, Stenson M, et al. Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation. Blood 2012;119:2844–2853.
   PubMed Web of Science ®Google Scholar
• Slack GW, Gascoyne RD. MYC and aggressive B-cell lymphomas. Adv Anat Pathol 2011;18:219–228.
   PubMed Web of Science ®Google Scholar
• Howell WM, Rose-Zerilli MJ. Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Fam Cancer 2006;5:143–149.
   PubMed Web of Science ®Google Scholar
• Meenagh A, Williams F, Ross OA, et al. Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America. Hum Immunol 2002;63: 1055–1061.
   PubMed Web of Science ®Google Scholar
• Mok CC, Lanchbury JS, Chan DW, et al. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1090–1095.
   PubMed Web of Science ®Google Scholar
• Hoffmann SC, Stanley EM, Cox ED, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002;2:560–567.
   PubMed Web of Science ®Google Scholar
• Padyukov L, Hahn-Zoric M, Lau YL, et al. Different allelic frequencies of several cytokine genes in Hong Kong Chinese and Swedish Caucasians. Genes Immun 2001;2:280–283.
   PubMed Web of Science ®Google Scholar
• Weiss KM, Terwilliger JD. How many diseases does it take to map a gene with SNPs?Nat Genet 2000;26:151–157.
   PubMed Web of Science ®Google Scholar
• Syvanen AC. Accessing genetic variation: genotyping single nucleotide polymorphisms. Nat Rev Genet 2001;2:930–942.
   PubMed Web of Science ®Google Scholar
• Reuss E, Fimmers R, Kruger A, et al. Differential regulation of interleukin-10 production by genetic and environmental factors—a twin study. Genes Immun 2002;3:407–413.
   PubMed Web of Science ®Google Scholar
• Moraes MO, Santos AR, Schonkeren JJ, et al. Interleukin-10 promoter haplotypes are differently distributed in the Brazilian versus the Dutch population. Immunogenetics 2003;54:896–899.
   PubMed Web of Science ®Google Scholar
• Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559–575.
   PubMed Web of Science ®Google Scholar
• Muller AM, Ihorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005;84:1–12.
   PubMed Web of Science ®Google Scholar
• Hosgood HD 3rd, Au WY, Kim HN, et al. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations. Int J Hematol 2013;97:793–799.
   PubMed Web of Science ®Google Scholar
• Wong HL, Breen EC, Pfeiffer RM, et al. Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study. AIDS 2010;24:1025–1033.
   PubMed Web of Science ®Google Scholar
• Cao HY, Zou P, Zhou H. Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis. Gene 2013;519:288–294.
   PubMed Web of Science ®Google Scholar
• Westendorp RG, Langermans JA, Huizinga TW, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170–173.
   PubMed Web of Science ®Google Scholar
• Grondal G, Kristjansdottir H, Gunnlaugsdottir B, et al. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. Arthritis Rheum 1999; 42:1649–1654.
   PubMed Web of Science ®Google Scholar
• Lech-Maranda E, Baseggio L, Bienvenu J, et al. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 2004;103:3529–3534.
   PubMed Web of Science ®Google Scholar